Basic Pharmacokinetics Bibliography
- Aronoff George R, et al: Drug Prescribing in Renal Failure. Philadelphia, PA. ACP, 1999.
- Bauer, Larry A. Applied Clinical Pharmacokinetics. McGraw-Hill. 2001.
- Evans W, Schentag J, Jusko J (eds): Applied Pharmacokinetics 3rd edition. San Francisco, CA. Applied Therapeutics, 1992.
- Murphy John E (Editor): Clinical Pharmacokinetics 2nd edition. Bethesda, MD. ASHP, 2001.
- Ritschel WA: Handbook of Basic Pharmacokinetics, 5th edition. Washington, DC. APhA, 1999.
- DiPiro JT, Blouid RA, Pruemer JM. Concepts in Clinical Pharmacokinetics. Bethesda, MD. ASHP, 1988.
- Caviness MD, MacKichan J, et al. Therapeutic Drug Monitoring: A guide to clinical application. Irving, TX. Abbott Labs, 1987.
- Winter, Michael: Basic Clinical Pharmacokinetics 4th Edition. Philadelphia, PA. Lippincott, 2004.
Creatinine Clearance Bibliography
-
Clinical Practice Guidelines for Estimation of GFR. National Kidney Foundation, 2002.
- Lott RS, Hayton WL: Estimation of Creatinine Clearance
from Serum Creatinine Concentration - a review. DICP. 1978;12:140-150.
- Hull JH, et al. Influence of range of renal function
and liver disease on predictability of creatinine clearance.
Clin Pharmacol Ther 1981;30:414-21.
- Sawyer WT, et al, Variables Affecting Creatinine
Clearance Prediction. Am J Hosp Pharm 1983;40:2175-80.
- Canaday BR, et al, Fractional Adjustment of Predicted
Creatinine Clearance in Females. Am J Hosp Pharm 1984;41:1842-3.
- Chow MS, Schweizer R, Estimation of Creatinine
Clearance in Patients with Unstable Serum Creatinine Concentrations:
Comparison of Multiple Methods. DICP. 1985;19:385-390.
- Bennett WM. Drug Therapy in Renal Disease. In:
Scientific American Medicine. New York: Scientific American Inc.,
1986: 10(II):A1-27.
- Mayersohn M. Special Pharmacokinetic Considerations
in the Elderly. In: Applied Pharmacokinetics, 2nd Edition.
Spokane, WA: Applied Therapeutics, Inc., 1986. pp 229-293.
- Gibson TP. Influence of Renal Disease on Pharmacokinetics.
In: Applied Pharmacokinetics, 2nd Edition. Spokane,
WA: Applied Therapeutics, Inc., 1986. pp 83-115.
- Rhodes PJ, et al: Evaluation of Eight Methods
for Estimating Creatinine Clearance in Men. Clin Pharm. 1987;6:399-406.
- Caldwell JR. Alterations in Renal Function in the Elderly
Population: Implications for Medication Prescribing. Cons Pharm. 1987;Supp B:3-7.
- Lipman AG. Drug Therapy Considerations in the Renally Compromised
Geriatric Patient. Cons Pharm. 1987;Supp B:3-7.
- Melamed AJ, Vanamee P. Estimating creatinine clearance in
patients with cancer. Hosp Pharm 1988;23:898-901.
- Drusano GL, et al. Commonly used methods of
estimating creatinine clearance are inadequate for elderly debilitated
nursing home patients. JAGS 1988;36:437-441.
- Lau AH, et al. Estimation of creatinine clearance
in malnourished patients. Clin Pharm 1988:7;62-65.
Aminoglycoside Bibliography
- Devine B, Gentamicin therapy. DICP 1974;8:650-655.
- Sarubbi FA, Hull JW. Gentamicin serum concentrations:
pharmacokinetic predicitions. Ann Intern Med 1976;85:183-189.
- Sawchuk RJ, Zaske DE, et al. Kinetic model for
gentamicin dosing. Clin Pharmacol Ther 1977;21;3:362-369.
- Sarubbi FA, Hull JW. Amikacin serum concentrations:
predicition of levels and dosage guidelines. Ann Intern Med
1978;89:612-618.
- Nicolau DP, et al. Experience with a once-daily aminoglycoside program
administered to 2,184 adult patients. Antimicrob Agents Chemo 1995;29;3:650-655.
- Blouin RA, et al. Tobramycin pharmacokinetics in morbidly
obese patients. Clin Pharmacol Ther 1979;26:508-513.
- Bauer LA, et al. Amikacin pharmacokinetics in
morbidly obese patients. Am J Hosp Pharmacy 1980;37:519-522.
- Korsager S. Administration of gentamicin to obese
patients. Int J Clin Pharmacol Ther Tox 1980;18,12:549-553.
- Lesar TS, et al. Gentamicin dosing errors with
four commonly used nomograms. JAMA 1982;248(10);1190-1193.
- Sheiner LB, Beal S. Bayesian individualization of pharmacokinetics: simple implementation
and comparison with non-Bayesian methods. J Pharm Sci 1982 71:1344-1348.
- Matzke GR, Burkle WS, Lucarotti RL. Gentamicin
and tobramycin dosing guidelines: an evaluation. DICP
1983;17:425-432.
- Yamaoka K, Nakagawa T, et al. A nonlinear multiple regression program based on Bayesian
algorithm for microcomputers. J. Pharmacobio-Dyn., 8, 246-256 1985.
- Burton ME, Brater DC, et al. A Bayesian feedback method of aminoglycoside dosing.
Clin Pharmacol Ther 37:349-357, 1985.
- Burton ME, Chow MSS, et al. Accuracy of Bayesian
and Sawchuk-Zaske dosing methods for gentamicin. Clin Pharm
1986;5:143-149.
- Zaske DE. "Aminoglycosides", in Evans
W, Schentag J, Jusko J (eds): Applied Pharmacokinetics. San Francisco.
Applied Therapeutics, 1986; pp 331-381.
- Schentag JJ, "Aminoglycosides", in
Evans W, Schentag J, Jusko J (eds): Applied Pharmacokinetics.
San Francisco. Applied Therapeutics, 1986; pp 382-398.
- Fant WK. Controversies in antimicrobial therapy:
Pitfalls in monitoring aminoglycoside therapy. AJHP
1986:43:641-645.
- Chrystyn H. Validation of the use of Bayesian analysis in the
optimization of gentamicin therapy. DICP 1988 22:49-53.
- Donahue T, Yates DJ. Predictability of aminoglycoside
serum levels dosed by a pharmacy protocol. Hospital Pharmacy
1988:23;11-25
- Rodvelt KA, Zokufa H, Rotschafer JC. Aminoglycoside
pharmacokinetic monitoring: An integral part of patient care?
Clin Pharm 1988:7:608-613.
- Okamoto MP, Chi A, et al. Comparison of two microcoputer Bayesian
pharmacokinetic programs for predicting serum gentamicin concentrations.
Clin Pharm 1990 9:708-11.
- Tsubaki T, Chandler MHH. Evaluating new and traditional
methods for aminoglycoside dosing with various degrees of renal
function. Pharmacotherapy 1994; 14:330-336.
- Anaizi N. Once-daily dosing of aminoglycosides.
A consensus document. Int J Clin Pharmacol Ther. 1997 Jun;35(6):223-6.
- Urban AW, Craig WA. Daily dosage of Aminoglycosides. Current Clinical
Topics in Infectious Diseases Vol 17, JS Remington & MN Swartz, Eds. Blackwell
Science, Malden, MA, 1997.
- Demczar DJ, Nafziger AN, Bertino JS. Pharmacokinetics of Gentamicin at
Traditional versus High Doses: Implications for Once-Daily Aminoglycoside Dosing.
Antimicrob Agents Chemother. 1997 41:1115-1119.
- Casano RA, Johnson DF, Bykhovskaya Y, Torricelli F, Bigozzi M, Fischel-Ghodsian N.
Inherited susceptibility to aminoglycoside ototoxicity: genetic heterogeneity and clinical implications. Am J Otolaryngol. 1999 May-Jun;20(3):151-6.
[ PubMed ]
- Hain, TC. Bilateral vestibulopathy. July 2007.
Vancomycin Bibliography
- Sheiner LB, Beal S. Bayesian individualization of pharmacokinetics: simple
implementation and comparison with non-Bayesian methods. J Pharm Sci 1982
71:1344-1348.
- Matzke GR, Kovarik JM, et al. Evaluation of the vancomycin-clearance:
creatinine-clearance relationship for predicting vancomycin dosage. Clin
Pharm 1985;4:311-315.
- Lake KS, Peterson CD. A simplified dosing method for initiating
vancomycin therapy. Pharmacotherapy 1985; 5:340-344.
- Yamaoka K, Nakagawa T, et al. A nonlinear multiple regression
program based on Bayesian algorithm for microcomputers.
J. Pharmacobio-Dyn., 8, 246-256 1985.
- Rybak MJ, Boike SC. Monitoring vancomycin therapy. DICP 1986;20:757-761.
- Matzke GR, Zhanel GG, Guay DRP. Clinical pharmacokinetics of
vancomycin. Clin Pharmaco 1986;11:257-282.
- Rybak MJ, Boike SC. Individualized adjustment of vancomycin dosage:
comparison with two dosage nomograms. DICP 1986;20:64-68.
- Cheung RP, DiPiro JT. Vancomycin: An Update. Pharmacotherapy 1986;6:153-69.
- Matzke GR. "Vancomycin" In: Applied Pharmacokinetics,
Second Edition. Spokane, WA: Applied Therapeutics, Inc., 1986. pp 399-436.
- Musa DM, Pauly DJ. Evaluation of a new vancomycin dosing method.
Pharmacotherapy 1987;7:69-72.
- Garrelts JC, Godley PJ, et al. Accuracy of Bayesian, Sawchuk-Zaske,
and nomogram dosing methods for vancomycin. Clin Pharm 1987;6:795-799.
- Rodvold KA, et al. Routine monitoring of serum vancomycin
concentrations: can waiting be justified? Clin Pharm 1987;6:655-658.
- Pyrka RD, Rodvold KA, et al. Individualizing vancomycin dosage regimens: one- versus
two-compartment Bayesian models. Ther Drug Mon 1989 11:45-454.
- Ackerman, Bruce H. Evaluation of three methods for determining
initial vancomycin doses. DICP 1989;23:123-7.
- Healy DP, et al. Vancomycin-induced histamine release and 'red
man syndrome' comparison of 1- and 2-hour infusions. Antimicrobial
Agents and Chemo 34; 550-554, 1990.
- Pryka RD, Rovold KA, Erdman SM. An updated comparison of drug
dosing methods part IV:vancomycin. Clin Pharmaco 1991;20:463-76.
- Ito M, Duren L, et al. Computer program for the initiation of
vancomycin therapy. Clin Pharm 1993 12:126-30.
- Leader WG, Chandler MH, and Castiglia M. Pharmacokinetic optimisation
of Vancomycin therapy. Clin Pharmacokinet 28(4);327-42 1995.
- Pou L, Rosell M, et al. Changes in vancomycin pharmacokinetics during
treatment. Ther Drug Mon 1996 18:149-153.